Literature DB >> 23034571

Cognitive behavioral therapy for schizophrenia: an empirical review.

Neil A Rector1, Aaron T Beck.   

Abstract

Early case studies and noncontrolled trial studies focusing on the treatment of delusions and hallucinations have laid the foundation for more recent developments in comprehensive cognitive behavioral therapy (CBT) interventions for schizophrenia. Seven randomized, controlled trial studies testing the efficacy of CBT for schizophrenia were identified by electronic search (MEDLINE and PsychInfo) and by personal correspondence. After a review of these studies, effect size (ES) estimates were computed to determine the statistical magnitude of clinical change in CBT and control treatment conditions. CBT has been shown to produce large clinical effects on measures of positive and negative symptoms of schizophrenia. Patients receiving routine care and adjunctive CBT have experienced additional benefits above and beyond the gains achieved with routine care and adjunctive supportive therapy. These results reveal promise for the role of CBT in the treatment of schizophrenia although additional research is required to test its efficacy, long-term durability, and impact on relapse rates and quality of life. Clinical refinements are needed also to help those who show only minimal benefit with the intervention.

Entities:  

Mesh:

Year:  2012        PMID: 23034571     DOI: 10.1097/NMD.0b013e31826dd9af

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  Psychotherapy in Contemporary Psychiatric Practice.

Authors:  George Hadjipavlou; Carlos A Sierra Hernandez; John S Ogrodniczuk
Journal:  Can J Psychiatry       Date:  2015-06       Impact factor: 4.356

Review 2.  The hearing voices network: initial lessons and future directions for mental health professionals and Systems of Care.

Authors:  Thomas Styron; Lauren Utter; Larry Davidson
Journal:  Psychiatr Q       Date:  2017-12

Review 3.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

4.  Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis.

Authors:  Marianne Bouchard; Tania Lecomte; Briana Cloutier; Jessica Herrera-Roberge; Stéphane Potvin
Journal:  Front Psychiatry       Date:  2022-05-12       Impact factor: 5.435

5.  Cognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia.

Authors:  Julia S Cordes; Krystyna A Mathiak; Miriam Dyck; Eliza M Alawi; Tilman J Gaber; Florian D Zepf; Martin Klasen; Mikhail Zvyagintsev; Ruben C Gur; Klaus Mathiak
Journal:  Front Behav Neurosci       Date:  2015-06-25       Impact factor: 3.558

6.  Reinforcement of Self-Regulated Brain Activity in Schizophrenia Patients Undergoing Rehabilitation.

Authors:  Renata Markiewicz; Beata Dobrowolska
Journal:  Biomed Res Int       Date:  2021-03-26       Impact factor: 3.411

7.  Alterations in Emotional Diversity Correspond With Increased Severity of Attenuated Positive and Negative Symptoms in the Clinical High-Risk Syndrome.

Authors:  Zachary Anderson; Tina Gupta; William Revelle; Claudia M Haase; Vijay A Mittal
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

8.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.